Comparative Effects of Stecco-fascial Manipulation and Rolfing Structural Integration in Patients With Piriformis Syndrome (Piriformis)

August 10, 2026 updated by: Danyal Ahmad

COMPARATIVE EFFECTS OF STECCO-FASCIAL MANIPULATION AND ROLFING STRUCTURAL INTEGRATION IN PATIENTS WITH PIRIFORMIS SYNDROME; A RANDOMIZED CLINICAL TRIAL

This study aims to compare the effectiveness of Stecco Fascial Manipulation and Rolfing Structural Integration in treating Piriformis syndrome, focusing on special outcomes like pain severity and functional outcomes.

comparison will be done to check the effectiveness of Stecco-fascial Manipulation and Rolfing Structural Integration on patients of both groups.

participants will:

  1. get the treatment according to their respective groups
  2. Both groups were given 4 sessions for 4 weeks.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Enrolling by invitation

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

This study will be a randomized clinical trial with a sample size of 42 participants as calculated with g power tool with 5% of attrition added. Subjects will be obtained by non- probability convenient sampling based on the inclusion and exclusion criteria. Participants will be randomly assigned into two groups, 21 subjects in each group. The group A will receive the stecco fascial manipulation along with the conventional therapy while group B will receive the rolfing structural integration along with conventional therapy. The conventional physiotherapy protocol will include TENS applied with a Hot- pack for 10 minutes that will be followed by piriformis stretch.The data analysis will be done by IBM SPSS 26.0 version. To check the normality Shaprio- Wilk test will be used.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
42

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
    • Punjab Province
      • Sambrial, Punjab Province, Pakistan, 51040
        • Raheem Surgical Hospital Sambrial
      • Sialkot, Punjab Province, Pakistan, 51310
        • Bethania Hospital Sialkot
      • Sialkot, Punjab Province, Pakistan, 51310
        • University of Management and technology Sialkot Campus

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. 25 to 45 age group.
  2. For at least four weeks, there has been unilateral buttock discomfort, either with or without posterior thigh pain included buttock pain, pain that worsened when sitting.
  3. Positive slump test and fair test decrease ranges of hip NPRS greater than

Exclusion Criteria:

  1. Previous pelvic, ipsilateral hip, lumbar, or sacroiliac surgery that would have confused pain source.
  2. Evidence of lumbar radiculopathy or another spinal condition that could be the origin of the symptoms (matching MRI/CT revealing nerve root compression or disc herniation). progressive neurologic disease or neuromuscular disease (e.g., peripheral neuropathy, myopathy, neuromuscular junction diseases)28.
  3. During the research period, pregnancy or the planning of pregnancy (if interventions are employed) active pelvic or hip infection, malignancy, fracture, or systemic inflammation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: GROUP A ( Stecco fascial Manipulation)
GROUP A ( Stecco fascial Manipulation) containing 21 participants who will be given Stecco fascial Manipulation for 30 minutes along with the conventional physiotherapy.
Other: Experimental: GROUP A ( Stecco fascial Manipulation)
Stecco-fascial manipulation primary reduces pain, improves range of motion, restores normal muscle recruitment link in myofascial sequences, facilitates healing by improving microcirculation and lymphatic drainage.
Experimental: GROUP B (Rolfing Structural Integration)
GROUP B (Rolfing Structural Integration) containing 21 participants who were given Rolfing Structural Integration for 30 minutes along with the conventional physiotherapy.
Other: Experimental: GROUP B (Rolfing Structural Integration)
Rolfing structural integration improves posture, reduces pain, lengthens fascial planes and enhances the movement efficiency. This research will determine which approach is more effective in treating the patient with piriformis syndrome.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Change From Baseline in Pain Intensity as Measured by the Numerical Pain Rating Rating Scale (NPRS)
Time Frame: 4 Weeks
The Numerical Pain Rating Scale (NPRS) is a self-intensity on an 11-point scale, ranging from 0 (no pain) to 10 (worst possible pain). It is widely used in both clinical and research demonstrated strong reliability and validity in measuring Scale (NPRS) is a self-reported tool used to assess pain point scale, ranging from 0 (no pain) to 10 (worst possible pain). It is research settings for musculoskeletal conditions, strong reliability and validity in measuring both acute and chronic pain reported tool used to assess pain point scale, ranging from 0 (no pain) to 10 (worst possible pain). It is conditions, and it has both acute and chronic pain
4 Weeks
Universal Goniometer
Time Frame: 4 Weeks
A goniometer is an instrument used objective and reliable values that help evaluate mobility limitations i disorders such as piriformis syndrome used to measure joint range of motion (ROM). It provides objective and reliable values that help evaluate mobility limitations in musculoskeletal disorders such as piriformis syndrome.
4 Weeks

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
FAIR Test
Time Frame: 4 Weeks
The FAIR (Flexion, Adduction, and Internal Rotation) test is a provocation test specifically designed for diagnosing piriformis syndrome. It reproduces symptoms by stretching the piriformis muscle, The FAIR (Flexion, Adduction, and Internal Rotation) test is a provocation test specifically designed for diagnosing piriformis syndrome. It reproduces symptoms by which may compress or irritate the sciatic nerve. The FAIR (Flexion, Adduction, and Internal Rotation) test is a provocation test specifically designed for diagnosing piriformis syndrome. It reproduces symptoms by sciatic nerve. This test has been validated as a reliable diagnostic too has been validated as a reliable diagnostic tool in piriformis-related case
4 Weeks
Slump Test
Time Frame: 4 Weeks
The Slump test is a neurodynamic examination used to assess neural tension, particularly performed by placing the patient in a seated slumped tension, particularly slumped position with controlled spinal and limb movements, helping to reproduce neurological symptoms The Slump test is a neurodynamic examination used to assess neural of the sciatic nerve. It is performed with controlled spinal and limb movements, helping to reproduce neurological symptoms associated with lumbosacral or piriformis with controlled spinal and limb movements, helping to reproduce neurological symptoms associated with lumbosacral or piriformis-related condition.
4 Weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Danyal Ahmad

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Hamza Zahid, MS OMPT, University of Management and Technology Sialkot Pakistan

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
March 1, 2025

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
March 30, 2026

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
August 30, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
December 22, 2025

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
December 22, 2025

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
January 7, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
August 12, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 10, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
August 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • kuhs/dpt/umt-skt-026

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings